EFFECT OF PLATELET-ACTIVATING-FACTOR ANTAGONIST CV3988 IN AN AUTOLOGOUS NEPHROTOXIC NEPHRITIS MODEL

被引：0
|
作者：
HRUBY, Z [1 ]
LOWRY, RP [1 ]
BLAIS, D [1 ]
机构：
[1] MCGILL UNIV,ROYAL VICTORIA HOSP,DEPT MED,MONTREAL H3A 1A1,QUEBEC,CANADA
来源：
CLINICAL RESEARCH | 1986年 / 34卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A602 / A602
页数：1
相关论文
共 50 条
  • [21] POSSIBLE ROLE OF PLATELET-ACTIVATING-FACTOR (PAF) IN DISSEMINATED INTRAVASCULAR COAGULATION (DIC), EVIDENCED BY USE OF A PAF ANTAGONIST, CV-3988
    IMURA, Y
    TERASHITA, Z
    NISHIKAWA, K
    LIFE SCIENCES, 1986, 39 (02) : 111 - 117
  • [22] EFFECT OF PLATELET-ACTIVATING-FACTOR ANTAGONIST ON BRAIN INJURY IN RATS
    TOKUTOMI, T
    SIGEMORI, M
    KIKUCHI, T
    HIROHATA, M
    ACTA NEUROCHIRURGICA, 1994, : 508 - 510
  • [23] EFFECT OF CV-3988, A SPECIFIC ANTAGONIST AGAINST PLATELET ACTIVATING FACTOR, ON HOMOLOGOUS PASSIVE CUTANEOUS ANAPHYLAXIS IN THE MOUSE EAR
    INAGAKI, N
    MIURA, T
    OHIRA, K
    NAGAI, H
    XU, Q
    KODA, A
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1990, 13 (05): : 272 - 277
  • [24] CV-6209, A HIGHLY POTENT ANTAGONIST OF PLATELET-ACTIVATING-FACTOR INVITRO AND INVIVO
    TERASHITA, ZI
    IMURA, Y
    TAKATANI, M
    TSUSHIMA, S
    NISHIKAWA, K
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1987, 242 (01): : 263 - 268
  • [25] INHIBITION OF ANTIGEN-INDUCED AIRWAY HYPERRESPONSIVENESS IN RATS - EFFECTS OF OZAGREL (A THROMBOXANE A(2) SYNTHASE INHIBITOR) AND OF CV-3988 (A PLATELET-ACTIVATING-FACTOR ANTAGONIST)
    MISAWA, M
    CHIBA, Y
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1994, 84 (03): : 341 - 349
  • [26] EFFECT OF TOPICAL PLATELET-ACTIVATING-FACTOR (PAF) ANTAGONIST ON RAT CORNEAS
    PENA, RA
    FRANK, K
    CROFT, KW
    DIECKERT, JP
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S135 - S135
  • [27] EFFECT OF PLATELET-ACTIVATING-FACTOR ANTAGONIST BN 52063 ON THE NEPHROTOXICITY OF CISPLATIN
    DOSSANTOS, OFP
    BOIM, MA
    BARROS, EJG
    PIROTZKY, E
    BRAQUET, P
    SCHOR, N
    LIPIDS, 1991, 26 (12) : 1324 - 1328
  • [28] PLATELET-ACTIVATING-FACTOR (PAF) ANTAGONISTS - DEVELOPMENT OF THE POTENT PAF ANTAGONIST, CV-6209
    TAKATANI, M
    YOSHIOKA, Y
    TASAKA, A
    TERASHITA, Z
    NISHIKAWA, K
    TSUSHIMA, S
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (11) : S174 - S174
  • [29] PLATELET-ACTIVATING-FACTOR ANTAGONIST AND CARDIOPULMONARY BYPASS - REPLY
    ZEHR, KJ
    CAMERON, DE
    ANNALS OF THORACIC SURGERY, 1995, 60 (03): : 744 - 745
  • [30] PLATELET-ACTIVATING-FACTOR ANTAGONIST ENHANCES LUNG PRESERVATION
    CORCORAN, PC
    WANG, YN
    KATZ, NM
    STLOUIS, JD
    FOEGH, ML
    RAJAN, SS
    ANALOUEI, AR
    WALLACE, RB
    JOURNAL OF SURGICAL RESEARCH, 1992, 52 (06) : 615 - 620
12345